Post-polypectomy bleeding in the English National Health Service Bowel Cancer Screening Programme

Abstract

Background and study aims Colonoscopic polypectomy reduces colorectal cancer incidence, but is associated with complications including post-polypectomy bleeding (PPB). PPB ranges in severity from minor to life-threatening, making interpretation and comparison difficult. No previous studies have examined PPB rate according to a standardized severity grading system. We aimed to determine the PPB rate stratified by severity grading, explore factors that contribute to PPB severity grading, and describe PPB management.

Methods Data relating to PPB were prospectively collected from all colonoscopies performed in one region of the English NHS Bowel Cancer Screening Programme (BCSP) from 06/12/2010 to 15/07/2014. PPB was defined and stratified into major, intermediate, and minor according to BCSP standardized definitions based on the American Society for Gastrointestinal Endoscopy adverse events lexicon.

Results A total of 15 285 colonoscopies (23 766 polypectomies) were analyzed. The PPB rate per colonoscopy was 0.44 % (95 % confidence interval [CI] 0.34 – 0.54) and the rate per polypectomy was 0.29 % (95 %CI 0.20 – 0.38); 2.9 % of PPBs were major and 42.6 % were intermediate. Repeat endoscopy occurred in 27.9 % and was the most common reason for bleeding being categorized as of intermediate severity, although therapy was applied in only 36.8 % of these cases. A therapeutic intervention was significantly more common in patients with PPB who had either a hemoglobin drop ≥ 2 g/dL and/or a blood transfusion (P = 0.04, relative risk 3.47, 95 %CI 1.05 – 11.52).

Conclusions This study specifically examined colonoscopic PPB rate, stratified using standardized criteria. The rates of PPB were low, with the majority of PPB being of minor severity. Current stratification of PPB severity combines measures of bleed severity with interventions. Using only hemoglobin drop ≥ 2 g/dL and/or blood transfusion as markers of PPB severity may simplify stratification, and allow a better assessment of the necessity and impact of an intervention.

• References

• 1 Gavin DR, Valori RM, Anderson JT. et al. The national colonoscopy audit: a nationwide assessment of the quality and safety of colonoscopy in the UK. Gut 2013; 62: 242-249
• 2 Logan RF, Patnick J, Nickerson C. et al. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 2012; 61: 1439-1446
• 3 Cotton PB, Eisen GM, Aabakken L. et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71: 446-4544
• 4 Chilton A, Rutter M. Quality assurance guidelines for colonoscopy. NHS BCSP Publ. 2011
• 5 Rex DK, Lewis BS, Waye JD. Colonoscopy and endoscopic therapy for delayed post-polypectomy hemorrhage. Gastrointest Endosc 1992; 38: 127-129
• 6 Macrae F, Tan KG, Williams CB. Towards safer colonoscopy: a report on the complications of 5000 diagnostic or therapeutic colonoscopies. Gut 1983; 24: 376-383
• 7 Viiala CH, Zimmerman M, Cullen DJE. et al. Complication rates of colonoscopy in an Australian teaching hospital environment. Intern Med J 2003; 33: 355-359
• 8 Singh H, Penfold RB, DeCoster C. et al. Colonoscopy and its complications across a Canadian regional health authority. Gastrointest Endosc 2009; 69: 665-671
• 9 Singh H, Penfold RB, Moffatt M. Predictors of serious complications associated with lower gastrointestinal endoscopy in a major city-wide health region. Can J Gastroenterol 2010; 24: 425-430
• 10 Rutter CM, Johnson E, Miglioretti DL. et al. Adverse events after screening and follow-up colonoscopy. Cancer Causes Control 2012; 23: 289-296
• 11 Rutter M, Nickerson C, Rees C. et al. Risk factors for adverse events related to polypectomy in the English Bowel Cancer Screening Programme. Endoscopy 2014; 46: 90-97
• 12 Heldwein W, Dollhopf M, Meining A. et al. The Munich Polypectomy Study (MUPS): prospective analysis of complications and risk factors in 4000 colonic snare polypectomies. Endoscopy 2005; 37: 1116-1122
• 13 Rosen L, Bub DS, Reed JF. et al. Hemorrhage following colonoscopic polypectomy. Dis Colon Rectum 1993; 36: 1126-1131
• 14 Sorbi D, Norton I, Conio M. et al. Postpolypectomy lower GI bleeding: descriptive analysis. Gastrointest Endosc 2000; 51: 690-696
• 15 Rathgaber SW, Wick TM. Colonoscopy completion and complication rates in a community gastroenterology practice. Gastrointest Endosc 2006; 64: 556-562
• 16 Saraya T, Ikematsu H, Fu KI. et al. Evaluation of complications related to therapeutic colonoscopy using the bipolar snare. Surg Endosc 2012; 26: 533-540
• 17 Rogers BH, Silvis SE, Nebel OT. et al. Complications of flexible fiberoptic colonoscopy and polypectomy. Gastrointest Endosc 1975; 22: 73-77
• 18 Dafnis G, Ekbom A, Pahlman L. et al. Complications of diagnostic and therapeutic colonoscopy within a defined population in Sweden. Gastrointest Endosc 2001; 54: 302-309
• 19 Wu X, Church JM, Jarrar A. et al. Risk factors for delayed postpolypectomy bleeding: how to minimize your patients’ risk. Int J Colorectal Dis 2013; 28: 1127-1134
• 20 Metz AJ, Bourke MJ, Moss A. et al. Factors that predict bleeding following endoscopic mucosal resection of large colonic lesions. Endoscopy 2011; 43: 506-511
• 21 Watabe H, Yamaji Y, Okamoto M. et al. Risk assessment for delayed hemorrhagic complication of colonic polypectomy: polyp-related factors and patient-related factors. Gastrointest Endosc 2006; 64: 73-78
• 22 Sawhney MS, Salfiti N, Nelson DB. et al. Risk factors for severe delayed postpolypectomy bleeding. Endoscopy 2008; 40;: 115-119
• 23 Zhang Q, An SL, Chen ZY. et al. Assessment of risk factors for delayed colonic post-polypectomy hemorrhage: a study of 15 553 polypectomies from 2005 to 2013. PLoS One 2014; 9: e108290
• 24 Kim JH, Lee HJ, Ahn JW. et al. Risk factors for delayed post-polypectomy hemorrhage: a case-control study. J Gastroenterol Hepatol 2013; 28: 645-649
• 25 Suzuki S, Chino A, Kishihara T. et al. Risk factors for bleeding after endoscopic submucosal dissection of colorectal neoplasms. World J Gastroenterol 2014; 20: 1839-1845
• 26 Lee TJW, Rutter MD, Blanks RG. et al. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme. Gut 2012; 61: 1050-1057
• 27 Veitch AM, Vanbiervliet G, Gershlick AH. et al. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Endoscopy 2016; 48: 385-402
• 28 Gibbs DH, Opelka FG, Beck DE. et al. Postpolypectomy colonic hemorrhage. Dis Colon Rectum 1996; 39: 806-810
• 29 Inoue T, Nishida T, Maekawa A. et al. Clinical features of post-polypectomy bleeding associated with heparin bridge therapy. Dig Endosc 2014; 26: 243-249
• 30 Pan A, Schlup M, Schultz M. The role of aspirin in post-polypectomy bleeding – a retrospective survey. BMC Gastroenterol 2012; 12: 138